Reckitt Benckiser Group (LON:RB) had its target price lifted by JPMorgan Chase & Co. from GBX 7,300 ($89.84) to GBX 8,000 ($98.45) in a research note released on Friday morning, Borsen Zeitung reports. They currently have an overweight rating on the stock.

Several other equities analysts have also recently issued reports on RB. Citigroup reaffirmed a buy rating on shares of Reckitt Benckiser Group in a research report on Thursday, June 18th. Barclays upped their price objective on Reckitt Benckiser Group from GBX 7,900 ($97.22) to GBX 9,000 ($110.76) and gave the company an overweight rating in a research report on Tuesday, June 23rd. Kepler Capital Markets upped their price objective on Reckitt Benckiser Group from GBX 6,700 ($82.45) to GBX 7,250 ($89.22) and gave the company a buy rating in a research report on Monday, May 4th. HSBC set a GBX 7,300 ($89.84) price objective on Reckitt Benckiser Group and gave the company a buy rating in a research report on Tuesday, May 12th. Finally, Morgan Stanley reaffirmed an overweight rating and issued a GBX 7,000 ($86.14) price objective on shares of Reckitt Benckiser Group in a research report on Monday, May 18th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and thirteen have issued a buy rating to the stock. Reckitt Benckiser Group has a consensus rating of Buy and an average target price of GBX 7,033.16 ($86.55).

Shares of RB opened at GBX 7,420 ($91.31) on Friday. The company has a quick ratio of 0.40, a current ratio of 0.56 and a debt-to-equity ratio of 130.80. The business’s 50 day moving average price is GBX 7,042.72 and its 200-day moving average price is GBX 6,386.60. Reckitt Benckiser Group has a 52 week low of GBX 5,130 ($63.13) and a 52 week high of GBX 8,191.30 ($100.80). The stock has a market cap of $51.62 billion and a P/E ratio of -13.99.

In other Reckitt Benckiser Group news, insider Nicandro Durante purchased 165 shares of the business’s stock in a transaction on Wednesday, May 27th. The stock was acquired at an average price of GBX 6,884 ($84.72) per share, for a total transaction of £11,358.60 ($13,978.10).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Article: When is a capital gain realized?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.